Margartito Martinez Cruz

Dr. Margartito Martinez Cruz


Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
IMIvan Ramos Martínez
Ivan Ramos Martínez
EMEdgar Gustavo Ramos Martínez
Edgar Gustavo Ramos Martínez
MCMarco Cerbón
Marco Cerbón
Armando Perez-TorresArmando Perez-Torres
Armando Perez-Torres
Laura Pérez-Campos MayoralLaura Pérez-Campos Mayoral
Laura Pérez-Campos Mayoral
Eduardo Perez-CamposEduardo Perez-Campos
Eduardo Perez-Campos
Glycosylation is a post-translational modification that affects the stability, structure, antigenicity and charge of proteins. In the immune system, glycosylation is involved in the regulation of ligand–receptor interactions, such as in B-cell and T-cell activating receptors. Alterations in glycosylation have been described in several autoimmune diseases, such as systemic lupus erythematosus (SLE), in which alterations have been found mainly in the glycosylation of B lymphocytes, T lymphocytes and immunoglobulins. In immunoglobulin G of lupus patients, a decrease in galactosylation, sialylation, and nucleotide fucose, as well as an increase in the N-acetylglucosamine bisector, are observed. These changes in glycoisolation affect the interactions of immunoglobulins with Fc receptors and are associated with pericarditis, proteinuria, nephritis, and the presence of antinuclear antibodies. In T cells, alterations have been described in the glycosylation of receptors involved in activation, such as the T cell receptor; these changes affect the affinity with their ligands and modulate the binding to endogenous lectins such as galectins. In T cells from lupus patients, a decrease in galectin 1 binding is observed, which could favor activation and reduce apoptosis. Furthermore, these alterations in glycosylation correlate with disease activity and clinical manifestations, and thus have potential use as biomarkers. In this review, we summarize findings on glycosylation alterations in SLE and how they relate to immune system defects and their clinical manifestations.

ITIrene N. Torres-Vences
Irene N. Torres-Vences
Eduardo Perez-CamposEduardo Perez-Campos
Eduardo Perez-Campos
MMMiguel-Angel Mayoral-Chávez
Miguel-Angel Mayoral-Chávez
Eduardo Perez-CamposEduardo Perez-Campos
Eduardo Perez-Campos
MCMargartito Martinez Cruz
Margartito Martinez Cruz
JAJuan J Alpuche
Juan J Alpuche
Burnout (BO) is a response to prolonged exposure to work-related stressors characterized by emotional exhaustion (EE), depersonalization (DP), and reduced personal accomplishment (PA). The police working environment includes continued critical life-threatening situations, violence, and injuries, among other related factors putting them at high risk of distress. The objective of this study was to evaluate the association between Burnout Syndrome and sociodemographic, occupational, and health factors in Mexican police officers. We applied the Maslach Burnout Inventory Human Services Survey (MBI-HSS) to 351 active members of the Mexican police workforce. In addition, a specific questionnaire identified the presence of chronic degenerative diseases, hypertension, diabetes, digestive diseases, self-perception of food quality, and hours of sleep. Furthermore, 23.36% of police workforces presented high levels of burnout; 44.16% of police were highly emotionally exhausted, 49.29% had lost empathy with people, and 41.03% presented low personal achievement. Moreover, the worst levels of the syndrome were present in people with a poor self-perceived health status, poor perception of diet quality, without regular mealtimes, bad sleep habits, and elevated Body Mass Index. Data suggest that in Mexican police officers, BO is dimensionally different from all other groups previously studied (DP > EE > PA).

9 May 2024 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
LGLeticia Lorena I Hernández González
Leticia Lorena I Hernández González
Laura Pérez-Campos MayoralLaura Pérez-Campos Mayoral
Laura Pérez-Campos Mayoral
María Teresa Hernández-HuertaMaría Teresa Hernández-Huerta
María Teresa Hernández-Huerta
GMGabriel Mayoral-Andrade
Gabriel Mayoral-Andrade
MCMargartito Martinez Cruz
Margartito Martinez Cruz
Eduardo Perez-CamposEduardo Perez-Campos
Eduardo Perez-Campos
Neutrophils, which constitute the most abundant leukocytes in human blood, emerge as crucial players in the induction of endothelial cell death and the modulation of endothelial cell responses under both physiological and pathological conditions. The hallmark of preeclampsia is endothelial dysfunction induced by systemic inflammation, in which neutrophils, particularly through the formation of neutrophil extracellular traps (NETs), play a pivotal role in the development and perpetuation of endothelial dysfunction and the hypertensive state. Considering the potential of numerous pharmaceutical agents to attenuate NET formation (NETosis) in preeclampsia, a comprehensive assessment of the extensively studied candidates becomes imperative. This review aims to identify mechanisms associated with the induction and negative regulation of NETs in the context of preeclampsia. We discuss potential drugs to modulate NETosis, such as NF-κβ inhibitors, vitamin D, and aspirin, and their association with mutagenicity and genotoxicity. Strong evidence supports the notion that molecules involved in the activation of NETs could serve as promising targets for the treatment of preeclampsia.

11 April 2017 in Current Vascular Pharmacology
Verified
Journal Article
Closed access
NCNancy Cortez-Espinosa
Nancy Cortez-Espinosa
Laura Pérez-Campos MayoralLaura Pérez-Campos Mayoral
Laura Pérez-Campos Mayoral
Eduardo Perez-CamposEduardo Perez-Campos
Eduardo Perez-Campos
Hector Alejandro Cabrera-FuentesHector Alejandro Cabrera-Fuentes
Hector Alejandro Cabrera-Fuentes
Eduardo Perez-CamposEduardo Perez-Campos
Eduardo Perez-Campos
PCPedro Hernandez Cruz
Pedro Hernandez Cruz
The association between type 2 diabetes mellitus (T2DM) and systemic inflammation may increase platelet reactivity and the accelerated development of vascular disease. Platelets are able to modulate the function of immune cells via the direct release of growth factors and pro-inflammatory chemokines through the production of microvesicles. The microvesicles trigger a transcellular delivery system of bioactive molecules to other cells acting as vectors in the exchange of biological information. Here, we consider the influence of platelets and platelet-derived microvesicles on cells of the immune system and the implications in the pathogenesis of T2DM.

7 November 2001 in Biochimica et Biophysica Acta (BBA) - General Subjects
Verified
Journal Article
Closed access
MCMargartito Martinez Cruz
Margartito Martinez Cruz
EZEdgar Zenteno
Edgar Zenteno
FCFélix Córdoba
Félix Córdoba

23 October 2015 in Molecules
Verified
Journal Article
Open access
PDF file
SMSergio Espíndola Mateos
Sergio Espíndola Mateos
CMCarlos Alberto Matias-Cervantes
Carlos Alberto Matias-Cervantes
EZEdgar Zenteno
Edgar Zenteno
MSMarie-Christine Slomianny
Marie-Christine Slomianny
JAJuan J Alpuche
Juan J Alpuche
MCMargartito Martinez Cruz
Margartito Martinez Cruz
β-Glucosidase (EC 3.2.1.21) is a prominent member of the GH1 family of glycoside hydrolases. The properties of this β-glucosidase appear to include resistance to temperature, urea, and iodoacetamide, and it is activated by 2-ME, similar to other members. β-Glucosidase from chayote (Sechium edule) was purified by ionic-interchange chromatography and molecular exclusion chromatography. Peptides detected by LC-ESI-MS/MS were compared with other β-glucosidases using the BLAST program. This enzyme is a 116 kDa protein composed of two sub-units of 58 kDa and shows homology with Cucumis sativus β-glucosidase (NCBI reference sequence XP_004154617.1), in which seven peptides were found with relative masses ranging from 874.3643 to 1587.8297. The stability of β-glucosidase depends on an initial concentration of 0.2 mg/mL of protein at pH 5.0 which decreases by 33% in a period of 30 h, and then stabilizes and is active for the next 5 days (pH 4.0 gives similar results). One hundred μg/mL β-D-glucose inhibited β-glucosidase activity by more than 50%. The enzyme had a Km of 4.88 mM with p-NPG and a Kcat of 10,000 min−1. The optimal conditions for the enzyme require a pH of 4.0 and a temperature of 50 °C.